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Abstract

Parabens are esters of p-hydroxybenzoates that are commonly found in everyday
consumer products as well as pharmaceuticals. They are often used in commercial products
to prevent bacterial growth as well as to provide extended shelf life, but they have been
shown to activate estrogen receptors in vivo, a contributing factor in human breast cancer
proliferation. Our lab has previously generated a multitude of paraben derivatives that do
not exhibit estrogenic activity. Many of these derivatives may have other safety concerns,
but gallate esters appear to have the least hazardous properties. The estrogenic,
antimicrobial, and antioxidant properties of the gallate ester family are unclear; therefore,
our lab has synthesized several non-commercially available gallate esters through a DCC
coupling reaction. To determine the viability of gallates as preservatives, minimum
inhibitory concentrations (MIC) were obtained against Staphylococcus epidermidis,
Staphylococcus aureus, and Serratia marcescens and were found to be comparable to
traditional parabens. Estrogenic activity was compared via MTT proliferation, LDH
cytotoxicity, and estradiol colorimetric competition ELISA assays, indicating gallate esters
do not upregulate estrogenic activity, while traditional parabens show increased cell
proliferation and upregulation of estradiol. Finally, through cyclic voltammetry and DPPH
colorimetric assays, gallate esters were determined to act as antioxidants through the
reduction of free radicals, where traditional parabens do not. These findings suggest gallate
esters could be a suitable antioxidative alternative for traditional parabens. Further work
should be completed to determine the magnitude of binding to the estrogen receptor and
the extent of the associated antagonistic properties of gallate esters.
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Chapter 1: Parabens as Preservatives

Parabens are alkyl esters of p-hydroxybenzoic acid and are frequently used as
preservatives in a variety of consumer products (Figure 1). They have been used in over
22,000 cosmetic products, including makeup, soap, etc., with an allowance of up to 0.8%
for a mixture of parabens or up to 0.4% of a single paraben. 1 While parabens are most
prevalent in cosmetics, they have also been found in a variety of food products, with an
allowance of up to 0.1%.2 A study in 2012 found that 91% of 267 food samples contained
methylparaben, followed by 63% containing propylparaben and 62% containing
ethylparaben.3 Finally, parabens even have been used in paper products, such as sanitary
wipes, with concentrations up to 0.3%.4 The frequency of paraben use can be attributed to
their antimicrobial properties.

Figure 1. Structure of a traditional paraben. Red portion represents the phenol, while the
black represents the alkyl ester. X corresponds to the number of methylenes present in the
alkyl chain where X=0-3 is typical for use in consumer products.

Parabens can prevent bacterial growth in consumer products, making them a viable
option for use as preservatives. There are many ways in which parabens prevent bacterial
growth, including inhibition of RNA, DNA, and protein synthesis,5 inhibition of cellular
respiration,6 and disruption of the cellular membrane (Figure 2).7
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Figure 2. Paraben modes of action. A) Increased membrane fluidity, considered primary
mechanism.7,14 B) Disruption of ionic gradients.11 C) Inhibition of cellular respiration
(damage to glucose transporters).6 D) Prevention of DNA & RNA synthesis, resulting in
inhibition of protein synthesis.5

When some bacteria, such as Escherichia coli, are exposed to parabens, DNA and RNA
synthesis is inhibited and likely contributes to inhibition of bacterial growth, as both
mechanisms are required for replication and protein synthesis.5 There has also been
evidence of irreversible inhibition of glycolysis in bacteria, which is necessary to produce
the energy needed for various vital functions within a cell. This inhibition is due in part to
irreversible damage to key enzymes by parabens, such as those in the phosphotransferase
system, which are responsible for transporting resources, such as sugars, into the bacteria
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cells.6 While the inhibition of DNA/RNA synthesis and glycolysis may partially contribute
to the prevention of bacterial growth, the primary mode of action is agreed to be through
the disruption of the cellular membrane.
Due to their overall non-polar nature, parabens become embedded in the cell
membrane of bacteria cells, leading to a variety of problems that can inhibit growth or
cause cell death. The alkyl ester is lipophilic and intercalates with the hydrophobic fatty
acid tails of the phospholipids within the lipid bilayer, while the phenolic portion (shown
in red in Figure 1) interacts with the polar head groups, increasing hydration of the
membrane.8 Elongation of the alkyl chain has been shown to increase the affinity of
parabens for the hydrophobic region of the lipid bilayer,9 likely contributing to a
corresponding increase of overall antimicrobial activity.10 Both of these interactions can
alter the organization and functions of the cell membrane.
One important alteration caused by the accumulation of parabens within the cell
membrane is the dissipation of important transmembrane gradients that are present across
bacterial membranes. An example of such is the induction of potassium efflux in E. coli
caused by the destabilization of the bacterial membrane.11 Parabens may mimic the activity
of pore-forming proteins, leading to increased permeability of the membrane and the
induction of potassium release from the cell. They may also interact with important
transmembrane proteins that control potassium release from a target cell, including OmpF
porin proteins.11 The movement of potassium out of a cell can be detrimental for survival
as it is necessary for many key functions within bacteria cells, including the activity of
intracellular enzymes, acting as a second messenger within signal transduction pathways,
and maintenance of pH, membrane potentials, and osmotic pressure.12 The dissipation of
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transmembrane gradients in the presence of parabens is not limited to potassium, and is
likely one of the main consequences of the disruption of cell membranes by parabens and
other phenolic compounds.
Most of the membrane disrupting activity of parabens can be attributed to the
presence of a phenol within its structure, as phenols are known contributors of cell
membrane damage in bacteria cells. Phenols are able to enter the cell membrane by simple
diffusion due to their amphiphilic nature, which can disturb the cell membrane structure.13
More specifically, phenols increase the fluidity of the cell membrane, leading to leakage
of important molecules, including nucleotides, amino acids, and inorganic ions. 14 While
the presence of alkyl chains on parabens does aid in their affinity for the cell membrane,
the presence of a phenol group grants parabens the ability to disrupt cellular membranes in
order to prevent bacterial growth. The efficacy of parabens as preservatives has therefore
led to its increased use in many consumer products and their FDA approval. Despite this,
recent controversy regarding the safety of parabens has led to a push for paraben-free
products.
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Chapter 2: Estrogenic Activities of Xenoestrogens

Parabens have been heavily scrutinized for their xenoestrogenic activity, resulting
in a demand for their removal from many consumer products. Xenoestrogens are a class of
endocrine disruptors that specifically mimic estrogen, a natural steroid hormone found
within the human body.15 These estrogen-mimics have a wide variety of structures;
however, common structural motifs include lipophilic phenolic rings and other
hydrophobic components, which are shared characteristics with estrogen.16 Xenoestrogens
can be produced naturally, such as phytoestrogens produced by plants, or synthetically,
such as pesticides, herbicides, and pharmaceuticals. The structures of some common
xenoestrogens are shown in Figure 3. Despite their differences in sources or structure, all
xenoestrogens have the defining ability to mimic estrogen and act as ligands for estrogen
receptors, resulting in a plethora of endocrine-disrupting activities.

Figure 3. Structures of common xenoestrogens. A) Estradiol is an endogenous hormone.
B) Bisphenol A is a synthetic chemical used in plastics. C) Daidzein is a phytoestrogen
found in soy plants.

Estrogen is a steroid hormone that is involved in many physiological processes
within both reproductive and non-reproductive systems. It is one of the main hormones
involved in the development of primary and secondary sexual characteristics, as well as
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embryonal and fetal neural development.17 There are three major forms of estrogen,
including estrone, estradiol, and estriol.17 Of these, estradiol is the most prevalent in
premenopausal women, and therefore the focus of our interests. Estradiol is synthesized
within the ovaries and is responsible for the development and maintenance of secondary
sex characteristics, including breast development18 and endometrium development.19 It is
also highly involved in regulation of the menstrual cycle and ovulation.20
As a hormone, estradiol acts as a messenger for a variety of receptors within the
human body; however, it functions primarily through its interactions with estrogen
receptors. There are two types of estrogen receptors, including estrogen receptor alpha
(ERα) and estrogen receptor beta (ERβ). ERα is primarily expressed in reproductive
tissues, such as the mammary glands, uterus, and ovaries, while ERβ is found in a wider
variety of tissues, including the prostate, colon, adipose tissue, and the immune system.21
Of the two types, ERα is of the most interest for this research, as overstimulation of this
receptor by estradiol and xenoestrogens can increase the risk of developing breast cancer.
ERα is activated by the binding of estradiol at the ligand binding cleft, specifically
through interactions of the phenolic portions of estradiol with various amino acids present
in the binding site. These interactions consist of hydrogen bonding between the phenol,
two amino acids (Glu-353 and Arg-394), and a water molecule, while the second hydroxyl
function interacts via hydrogen bonding with a single amino acid (His-524).22 Figure 4
shows the binding interactions for estradiol and xenoestrogens in general. Estrogen is the
only steroidal hormone that contains a phenolic function, thus its involvement in binding
is presumably the unique interaction for the estrogen receptor. Considering the interactions
between ERα and estradiol, it is unsurprising that many xenoestrogen structures share the
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phenolic and/or hydrophobic functions. While all xenoestrogens are categorized by their
ability to mimic and trigger responses like those of estrogen, the small differences in their
“fits” leads to small differences in response by the estrogen receptors. Parabens are not
excluded from this, as the presence of a phenol within their structure allows them to bind
and activate ERα.15

Figure 4. Specific interactions of ligands with the estrogen receptor (ER) binding pocket.
The left shows the interactions of 17β-estradiol with the ER,22 while the right shows the
interactions of a generic xenoestrogen structure with the ER.

Parabens, as well as other xenoestrogens, can bind to ERα through phenolic binding
interactions, resulting in a variety of endocrine-disrupting activities that can modulate
various functions within the human body. When the ERα is activated by a ligand, a
resulting conformational change occurs, in turn causing the dimerization of two estrogen
receptors. This dimer is then able to bind to a specific DNA region called the Estrogen
Responsive Element (ERE), which can activate gene expression in response to the presence
of estradiol and/or xenoestrogens.23 This binding leads to the transcription of genes
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involved in various cellular processes, including production of estrogen and cell
proliferation.22,24 Therefore, overstimulation of ERα by estradiol and/or xenoestrogens can
increase proliferation of cells within reproductive tissue, including breast tissue.
One of the main concerns of paraben use in consumer products is their potential to
increase risk of developing breast cancer. This increased risk is due to their ability to
overstimulate ERα at low concentrations, resulting in the overproduction of estrogen and
abnormal cell proliferation within breast tissues.25 Higher proliferation rates correspond to
higher risk of developing cancer-causing mutations within DNA; therefore, exposure to
parabens can be associated with higher risks of developing breast cancer. Because
approximately 80% of breast cancers are hormone receptor positive (including ER), with
malignant growth resulting from increased levels of estrogen, the estrogenic activity of
parabens is a safety concern that cannot be ignored.26 In addition to their estrogenic
activity, other safety concerns must be considered, including their involvement in redox
chemistry. There is some evidence that suggests parabens may cause oxidative stress within
cells through their involvement in redox chemistry, which could further link their
involvement in the development of breast cancer through damage to DNA.
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Chapter 3: Redox Chemistry & Oxidative Stress

Redox reactions, or oxidation-reduction reactions, are a type of reaction that
involves an exchange of electrons between the atoms involved. These types of reactions
are common in biological systems, as they are often utilized to store or release energy
necessary for cellular functions. One important example of redox reactions within cells is
during cellular respiration, in which glucose is oxidized to produce carbon dioxide and
oxygen is reduced to form water. The combination of these redox reactions allows cells to
produce ATP, which is used as an energy source for many other cellular functions.
While redox reactions are important for many biological functions, they also come
with a risk of producing reactive oxygen species (ROS). Some examples of ROS produced
as metabolic byproducts include free radicals that have highly reactive, unpaired electrons,
such as superoxide and hydroxyl radicals, as well as other reactive species, like hydrogen
peroxide and singlet oxygen.27,28 ROS production is not limited to biologically inherent
redox reactions; however, as they can also be produced after exposure to environmental
pollutants, heavy metals, pharmaceutical drugs, chemical solvents, alcohol, and
radiation.29,30 The degradation or metabolism of these within biological systems often
produces free radical byproducts.
Low levels of ROS are necessary for cellular processes, including but not limited
to protein phosphorylation, activation of various transcription factors, apoptosis, immunity,
and even cell differentiation.31 An accumulation of excess ROS, however, can lead to a
phenomenon called oxidative stress.32,33 Oxidative stress is characterized as an imbalance
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between ROS and antioxidants, during which high levels of ROS can cause damage to all
cell structures, including proteins, lipids, and nucleic acids (Figure 5).34 The damage to
cellular structures from oxidative stress can be responsible for the development of various
diseases, such as cancer, diabetes, metabolic disorders, atherosclerosis, and cardiovascular
disease.35

Figure 5. Oxidative stress as a result of reactive oxygen species (ROS) accumulation.
High levels of ROS causes damage to all cellular structures, including cell membrane,
DNA, and proteins.34

One known source of oxidative stress and its associated complications is through
exposure to phenolic compounds. For example, skin exposure to phenol has been found to
be toxic, causing skin rash, dermal inflammation, contact dermatitis, depigmentation, and
even cancer promotion.36,37 The presence of a hydroxyl group within the phenolic function
allows phenolic compounds to participate in redox chemistry and contribute to oxidative
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stress. More specifically, one-electron oxidation of phenolic compounds by metabolic
enzymes produces their free radical intermediates that can cause cytotoxic and genotoxic
effects (Figure 6).37 Phenolic compounds are even suspected to be involved in redoxcycling, in which their free radical intermediates are reduced by intracellular reductants,
such as thiols. This results in regeneration of the parent phenolic compounds, which may
continue cycling through the enzymatic redox reactions and contributing to oxidative
stress.

Figure 6. Oxidation of phenolic compounds by hydrogen abstraction. A) Monophenols
undergo a single, one-electron oxidation to form a free radical (in red). Multiple oxidations
are very difficult and unlikely to happen; however, redox-cycling is possible and can
regenerate the parent compound.37 B) Polyphenols can undergo multiple, one-electron
oxidations to stabilize a free radical. The final quinone product is much less reactive,
leading to antioxidant behavior.45

The phenolic function within parabens is a major safety concern, as it allows them
to participate in redox chemistry that can cause oxidative stress. The contribution of
methylparaben to oxidative stress has been studied in rats, showing that it can cause lipid
peroxidation, a source of oxidative stress in which the free radical metabolites of
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methylparaben “steal” electrons from lipids within cell membranes. 38 Lipid peroxidation
is associated with damage to cell membranes and is associated with various pathologies
and diseases, such as cancer.39 Butylparaben also has been discovered to promote the
production of intracellular ROS in human trophoblasts, a type of cell that is important in
fetal development, which can in turn induce cell apoptosis through the release of calcium
ions and mitochondrial dysfunction.40 The ability to form free radical species may further
link the involvement of parabens in the development of breast cancer, as oxygen free
radicals can cause oxidative damage and mutations within DNA, a known cause of cancer
development;41 however, this link has not yet been confirmed.
Considering cells are highly susceptible to oxidative stress, there are natural
biological mechanisms in which accumulation of excess ROS can be prevented. One such
mechanism is through the production and use of antioxidants, a class of molecules that
protect cells from oxidative damage caused by ROS. Antioxidants can provide this
protection by either indirectly preventing the oxidation of molecules that usually form free
radicals through the regulation of free radical generating enzymes, or through free radical
neutralization by accepting or donating electrons to eliminate the highly reactive, existing
free radicals.42 The body produces a few antioxidants on its own, one of which is
glutathione, a tripeptide that is able to reduce ROS through a thiol-containing cysteine
group.43 While glutathione is an extremely powerful antioxidant, it cannot maintain
oxidative homeostasis on its own, making it very important to obtain antioxidants from the
diet.
There are many dietary antioxidants, including important vitamins and
phytochemicals. For example, vitamin C and E both accept a stable free radical state to
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prevent oxidative damage.42 Flavonoids, a class of plant-derived phenolic compounds, are
another important source of antioxidants, whose antiradical feature is strongly dependent
on its chemical structure.44 The structures of many flavonoids include polyphenolic
functions, in which multiple hydroxyl groups are bound to the aromatic rings. The presence
of multiple hydroxyl groups has been found to increase the antioxidant activity, likely due
to the ability to undergo several oxidations to form a stable quinone radical (Figure 6).45
While polyphenols can be beneficial if they are able to act as antioxidants, they still
have the potential to act as pro-oxidants. Their ability to participate in redox chemistry
allows them to be involved in the generation of ROS, as well as the scavenging of free
radicals.46 The balance between antioxidant and pro-oxidant activity heavily depends on
the feasibility of multiple oxidations and the stability of the radicals formed. This makes
the redox chemistry of phenols and polyphenols quite complicated; however, the potential
benefits of polyphenols as antioxidants could be applied to parabens to minimize the prooxidant activities that have been observed and improve their overall safety.
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Chapter 4: Substituted Parabens as a Lead

The rising concern regarding the safety of paraben use has not only led to a push
for paraben-free products by consumers, but has also inspired scientific interest in
discovering methods to improve paraben safety. One strategy has been through 3,5substitution of the phenolic function, shown in Figure 7. Initial interest in substituted
parabens resulted from the detection of parabens in aquatic environments, including river
water47 and sewage treatment plants.48 Further investigation of parabens in chlorinated
water, such as tap water, revealed the kinetically favorable chlorination of parabens at the
3- and 5- positions on the phenolic ring in the presence of free chlorine.49 This coincidental
discovery of 3,5-dichlorinated parabens resulted in a new lead for improving the safety of
parabens through substitution.

Figure 7. Structure of 3,5-substituted parabens. X and Y are on the 3,5-position of the
phenolic function. Z groups are on the 4,6-positions of the phenolic function. R represents
the alkyl chain of the derivatives.

While it became clear that parabens are favorably chlorinated in chlorinecontaining bodies of water, the effects of this chlorination on the properties of parabens
had not been investigated. In an initial lead study, Terasaki and co-workers were interested
in investigating the effect of mono- and dichlorination of parabens on the estrogenic
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activity of parabens.50 An estradiol competition enzyme-linked immunosorbent assay
(ELISA) was used to compare the estrogenic activity of the chlorinated parabens compared
to traditional parabens. The results of this study revealed that chlorinated derivatives of
parabens exhibited considerably weaker ERα activity or no activity at all. These findings
were significant, as they presented a potential avenue for minimizing the estrogenic activity
and improving the safety of parabens through substitution.
After discovering this initial lead, our lab became interested in further exploring the
potential of 3,5-substitution of parabens. It was hypothesized that 3,5-substitution sterically
blocked binding to ERα, resulting in the observed weakening of estrogenic activity.
Bergquist and co-workers synthesized a library of 3,5-substituted parabens, included in
Figure 7, to determine the effect of various substituent types on the estrogenic and
antimicrobial activities of parabens.51 Microdilution assays against Staphylococcus aureus
revealed improved antimicrobial abilities for many of the derivatives when compared to
butylparaben, a commonly used paraben derivative (Table 1). An estradiol competition
ELISA failed to show estrogenic activity for the substituted derivatives, while both
ethylparaben and butylparaben showed estrogenic stimulation. Finally, a terbium-based
time-resolved fluorescence resonance energy transfer (TR-FRET) binding assay revealed
that the substituted derivatives were still able to bind to ERα, though weakly compared to
butylparaben and estradiol (Table 1). These findings suggest that the 3,5-substituted
parabens are still able to bind to ERα but are unable to cause activation.
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Table 1. Minimum inhibitory concentration and TR-FRET Analysis data from Bergquist
et. al.51 X,Y,Z represent the substituents present on the phenolic function, while R
represents the alkyl ester chain. MIC values represent the lowest concentration necessary
for inhibition of bacteria growth, while IC50 values represent the concentration necessary
to bind 50% of the estrogen receptors through displacement of a fluorescent tracer.
X, Y, Z

R

F, F, F
Cl, Cl, H
Br, Br, H
Br, H, H
I, I, H
I, H, H
CH3, CH3, H
t
Bu, tBu, H
OH, OH, H
OMe, OMe, H
NO2, NO2, H
I, I, H
CH3, CH3, H
OH, OH, H
NO2, NO2, H
H, H, H

butyl
butyl
butyl
butyl
butyl
butyl
butyl
butyl
butyl
butyl
butyl
octyl
octyl
octyl
octyl
butyl

S. aureus MIC
μg/mL (μM)
128 (483)
64 (245)
32 (91)
64 (236)
16 (36)
64 (199)
>256 (>1045)
>256 (834)
512 (2055)
>256 (924)
512 (1809)
16 (31.8)
64 (213)
64 (210)
16 (47)
256 (1320)

TR-FRET IC50
(nM)
29400
55300
39400
8210
34600
7980
32500
>200000
8970
>200000
>200000
13200
16200
8740
60400
1420

The findings of our lab’s previous studies were surprising, as they revealed the
possible antagonistic ERα activity of 3,5-substituted parabens.51 A further study by Sasaki
and Terasaki studied both the agonistic and antagonistic properties of mono- and
dibrominated parabens.52 The agonistic studies revealed that bromination of parabens
prevented agonistic activity, or activation of ERα. On the other hand, the antagonistic
studies revealed higher antagonistic activity with increased bromination, meaning the
dibrominated parabens showed greater antagonistic activity than the monobrominated
derivatives. These findings elucidated that brominated parabens are able to bind to ERα
and prevent its activity to some extent. While this type of testing has not been completed
for the other 3,5-substituted derivatives that our lab has previously studied, the antagonistic
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properties of the brominated parabens could explain the binding and estrogenic activities
for the other substituted derivatives as well.
The 3,5-substituted parabens that our lab has synthesized could potentially be safer
for use in consumer products due to their decreased estrogenic activity; however, other
safety concerns must be considered to determine which of the derivatives might be the best
option. In general, halogenated organic compounds, such as halogenated phenols, are toxic
and should be avoided. Many halogenated phenols are used commercially as flame
retardants

and

wood

preservatives,

including

tribromophenol

(tri-BPh)53

and

pentachlorophenol (PCP).54 PCP is extremely toxic, with a known ability to cause cancer
and birth defects in laboratory animal studies, as well as blood disorders and nerve damage
in humans.55 While these dangers have not been assessed for the brominated and
chlorinated parabens, it is best to consider alternative derivatives that are not as likely to
be toxic. Further investigation into the potential benefits of polyphenols and their ability to
act as antioxidants has led to interest in evaluating gallate esters as a potentially safer
alternative to traditional parabens.
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Chapter 5: Preliminary Work & Research Goals

The use of parabens in consumer products has been an ongoing safety concern. This
is due to their ability to act as xenoestrogens, as well as their ability to participate in redox
chemistry and contribute to oxidative stress. An ideal alternative would be one that does
not exhibit either of these properties, making it much safer for use in consumer products.
Therefore, the focus of this research was to evaluate the safety of gallate esters, including
their estrogenic and antioxidant/pro-oxidant activities.
While gallate esters have been studied in the past to some extent, there are many
gaps in the literature regarding their viability as preservatives. This is likely due to the
limited accessibility of gallate ester derivatives through commercial means, particularly
those consisting of odd-numbered carbon chains. Previous studies have attempted to
evaluate their antimicrobial properties; however, they have only performed the necessary
biological assays on the commercially available derivatives, providing limited information
about the full range of gallate ester derivatives.
Before beginning studies regarding the safety of gallate esters, a broader range of
derivatives needed to be available. Therefore, our lab synthesized several derivatives that
were not commercially available, including pentyl, hexyl, heptyl, and decyl gallate esters,
shown in Figure 8.
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Figure 8. Non-commercially available gallate esters previously synthesized by our lab.
Percent yields are included as parentheticals for each compound.

Initially, synthesis was completed using a Fischer esterification reaction (Scheme 1);
however, the oxidative nature of sulfuric acid and high reflux temperatures led to products
that were dark-colored and potentially quinones.

Scheme 1. Fischer esterification reaction. *ROH denotes the alcohol used with varying
carbon chain lengths.

To combat this, synthetic methods were changed to a DCC coupling reaction (Scheme 2),
in which heat was not required and the resulting products were white powders, like the
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commercially available derivatives. The yields of this reaction were not as high, especially
for the longer-chained derivatives like decyl gallate, likely explaining the limited
commercial availability of gallate esters.

Scheme 2. DCC coupling reaction. *ROH denotes the alcohol used with varying carbon
chain lengths.

After completing the synthesis, the full range of gallate esters needed to be
evaluated for their ability to act as preservatives. Our lab completed microdilution assays
to obtain the minimum inhibitory concentrations (MIC) against three different bacteria,
including Staphylococcus epidermidis and Staphylococcus aureus as Gram-positive
representatives, and Serratia marcescens as a Gram-negative representative. The MIC
represents the lowest concentration of each compound required to prevent bacterial growth.
The results, found in Table 2, indicate that increasing the alkyl chain length improves the
MIC against gram-positive bacteria, with dodecyl gallate being the most effective
antimicrobial agent of the derivatives. Overall, the findings further support the viability of
gallate esters as preservative agents, justifying the evaluation of their safety to a greater
extent.
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Table 2. Minimum inhibitory concentration (MIC) of gallate esters against bacterial
growth. S. epidermidis and S. aureus are gram-positive, while S. marcescens is gramnegative.

a
b

Compound

Source

Methyl gallate
Ethyl gallate
Propyl gallate
Butyl gallate
Pentyl gallate
Hexyl gallate
Heptyl gallate
Octyl gallate
Decyl gallate
Dodecyl gallate
Ampicillin
Erythromycin

purchased
purchased
purchased
purchased
synthesized
synthesized
synthesized
purchased
synthesized
purchased
purchased
purchased

MIC (S.
epidermidis)
(μg/mL)
>512
>512
>512
512
256
128
64
128
64
32
>512
>512

MIC (S.
marcescens)
(μg/mL)
>512
>512
>512
>512
512
256
----b
256
----b
>512
>512
----b

MIC (S.
aureus)
(μg/mL)
512
>512
512
512
128
128
32
32
64
32-128a
8
16

Solubility leading to inconsistent results.
Not yet tested.

With the knowledge that gallate esters prevent bacterial growth, the evaluation of
their estrogenic and redox safety concerns could finally be completed. This began with the
use of an estradiol colorimetric competition enzyme-linked immunosorbent assay (ELISA)
to determine whether gallate esters act as xenoestrogens. The estradiol colorimetric
competition ELISA provides information about the estrogenic activities of a potential
xenoestrogen by detecting the upregulation of estrogenic activity. More specifically, the
production of estradiol by cells is determined using absorbance spectroscopy at 405 nm to
calculate the concentration of estradiol. If a compound upregulates estrogenic activity, the
estradiol production increases, suggesting the ability to bind and activate the estrogen
receptor. This method has been previously used for 3,5-substituted parabens,50 ,51 including
a few gallate esters,51 making it a suitable method for evaluating the estrogenic activity of
the full range of gallate ester derivatives.
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Next, the redox behavior and antioxidant properties of gallate esters were evaluated
through two different methods. The first method used was a 2,2-diphenyl-1-picrylhydrazyl
(DPPH) colorimetric assay, which detects the ability to scavenge a free radical and is an
accepted method for screening the antioxidant activity of phenolic compounds.56 In this
assay, DPPH begins as a free radical of a purple color and will become yellow when
exposed to an antioxidant as a result of hydrogen abstraction (Figure 9). Absorbance
spectroscopy at 490 nm can be used over time to measure this color change and calculate
anti-radical power of a compound. The DPPH assay can directly measure the antioxidant
capabilities of a compound relative to the DPPH radical with a known oxidation potential.

Figure 9. Mechanism of DPPH radical scavenging assay. Absorbance at 490 nm is used
to measure the color change after exposure to an antioxidant.

The redox behavior of gallate esters was more generally evaluated by determining
the redox potential of the compounds through cyclic voltammetry (CV). This
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electrochemical method was used to measure the oxidation potentials of gallate esters,
which in turn provides insight into their antioxidant properties. CV has been used for the
determination of antioxidant capabilities in the same manner as the more widely used
DPPH assay because of the correlation between low oxidation potentials and anti-radical
power.57 Additionally, there have been studies in which CV has been successfully used to
evaluate the antioxidant properties of parabens,58 gallic acid,57 and dodecyl gallate.59 The
results from CV can provide more general information regarding the ability to oxidize a
molecule, which can contribute to whether a molecule will act as an antioxidant through
free radical exchange.
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Chapter 6: Results & Discussion

Evaluation of estrogenic activities
Prior to completing the estradiol colorimetric competition ELISA, it was necessary
to determine the ability of gallate esters to stimulate cellular proliferation and/or trigger
cell death. To do so, lactate dehydrogenase (LDH) cytotoxicity and 3-(4,5-dimethylthiazol2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) proliferation assays were completed
using MCF-7 breast cancer cells, a human cell line that is positive for estrogen receptor
expression. During these assays, methyl- and butylparaben were used as examples of
traditional parabens, as they are both widely used in consumer products, and estradiol was
used as a control. Both assays were completed in biological triplicate over 24 and 72 hours,
and the results of one representative biological replicate are shown in Figure 10.

Dose response of MCF-7 cell
death
% cytotoxicity

40
20
0
-20

Methyl
Ethyl
Propyl
Butyl
Pentyl
Hexyl
Heptyl
Octyl
Decyl
Dodecyl
MeP
BuP
Estrogen
DMSO

% Proliferation

60

1 µg/mL

8 µg/mL

64 µg/mL

A.

128 µg/mL

90
70
50
30
10
-10

Methyl
Ethyl
Propyl
Butyl
Pentyl
Hexyl
Heptyl
Octyl
Decyl
Dodecyl
Estrogen
MeP
BuP
DMSO

Dose response of MCF-7 cell
proliferation

1 µg/mL

8 µg/mL

64 µg/mL

128 µg/mL

B.

Figure 10. Preliminary viability and cytotoxicity assays using MCF-7 cells. A) LDH
cytotoxicity assay of gallate esters. B) MTT proliferation of gallate esters.
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The results of the MTT proliferation assays demonstrated that gallate esters did not
stimulate cellular proliferation compared to MCF-7 cells alone, while both paraben
derivatives and estradiol stimulated MCF-7 proliferation to a similar degree (Figure 10A).
It was unsurprising that both paraben derivatives stimulated proliferation of MCF-7 cells,
as stimulation of the ER may contribute to increased proliferation. The results were
consistent with our lab’s previous work, in which neither butyl nor octyl gallate stimulated
MCF-7 proliferation, while butylparaben did.51 Despite this, it was still necessary to further
examine the estrogenic activity of each compound using a more specified approach, such
as an estradiol colorimetric competition ELISA, as cellular proliferation can be caused by
biological processes other than ER stimulation. Additionally, LDH cytotoxicity assays
revealed that no significant cell death was caused by any of the compounds studied,
including all gallate ester derivatives and paraben derivatives, in comparison to MCF-7
cells alone (Figure 10B). This was also consistent with our previous work, in which none
of the 3,5-substituted parabens caused cell death. The results of the LDH assays
demonstrated that all compounds did not affect the viability of MCF-7 cells. In summary,
the results of both assays confirmed that gallate esters were suitable for ELISA testing and
ensured the data provided from the ELISA would not be skewed by changes in either cell
proliferation or cell death caused by exposure to the compounds studied.
Once the MTT proliferation and LDH cytotoxicity assays were completed, an
estradiol colorimetric competition ELISA was used to evaluate the estrogenic activity of
gallate esters compared to parabens. As before, the ELISA assays were completed in
triplicate using the MCF-7 cell line cultures exposed to the studied compounds for 24
hours, and the results of one representative biological replicate are shown in Figure 11.
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Dose repsonse of estradiol competition ELISA
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Figure 11. Estradiol colorimetric competition ELISA using MCF-7 cells. Represents one
biological replicate of three completed. *Concentration constant in all wells.

The results of the ELISA revealed no upregulation of estrogenic activity by gallate
esters, as estradiol production was comparable to that of MCF-7 cells alone. In contrast,
both paraben derivatives showed upregulation of estradiol activity, with exponentially
higher amounts of estradiol produced. Both results are consistent with our previous work,
in which butyl and octyl gallate did not show estrogenic activity, while butyl paraben did.
Our previous work also consisted of TR-FRET binding assays, in which butyl and octyl
gallate showed increased binding affinities compared to the other 3,5-substituted parabens,
with half-maximal inhibitory concentration (IC50) values of 8970 nM and 8740 nM,
respectively.51 The results of these ELISA assays, in combination with previous the binding
data, suggest that gallate esters likely act as antagonists for the ER, binding and preventing
the activation of the ER by estradiol and other xenoestrogens.
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Evaluation of antioxidant capabilities
The antioxidant properties of gallate esters were measured in two ways, the first
being through a set of DPPH radical scavenging assays. To do so, the DPPH radical was
exposed to each compound at various molar ratios, including gallate esters, methyl- and
butylparaben, and vitamin C as a control. The absorbances were then collected over time
to determine the dose response of DPPH absorbance and half-maximal effective
concentration (EC50) for each compound. An example of a dose response plot and EC50
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plot for decyl gallate is shown in Figure 12.
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Figure 12. DPPH radical scavenging assay for decyl gallate. A) Dose response of DPPH
absorption. B) EC50 plot for DPPH reduction.

These assays were once again completed in triplicate and the resulting sets of data were
averaged to produce Table 3, which shows the EC50 and anti-radical powers (ARP), or the
inverse of the EC50, for all compounds studied.
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Table 3. Determined EC50 for DPPH reduction and antiradical power (ARP) of gallate
esters. DPPH assays were completed in triplicate for all compounds and averaged to
produce the following results.
Compound
Ascorbic Acid (Vit C)
Methyl gallate
Ethyl gallate
Propyl gallate
Butyl gallate
Pentyl gallate
Hexyl gallate
Heptyl gallate
Octyl gallate
Decyl gallate
Dodecyl gallate
Methyl paraben
Butyl paraben

Avg EC50
0.497
0.0323
0.0728
0.0803
0.0804
0.0540
0.0950
0.0957
0.0838
0.127
0.0988
-

Stdev EC50
0.04
0.02
0.01
0.01
0.003
0.01
0.01
0.02
0.01
0.02
0.01
-

ARP
2.01
30.9
13.7
12.5
12.4
18.5
10.5
10.4
11.9
7.88
10.1
-

During all trials of the DPPH assays, gallate esters were able to reduce the free
radical form of DPPH, resulting in the yellow, reduced form of DPPH. The gallate esters
were also able to do this with minimal EC50 values and high ARP values compared to
vitamin C, a known antioxidant. For the most part, the EC50 values and ARP values were
similar for all derivatives, ranging between 7.8 and 18.5, with methyl gallate being an
exception. For methyl gallate, there was a larger range of EC50 values between trials,
ranging from 0.00767 to 0.0472, leading to a much higher average ARP value of 30.9 and
a standard deviation almost twice that of the other gallate derivatives. This suggests that
methyl gallate may exhibit stronger antioxidant properties than the other derivatives;
however, more replicates would be necessary to provide a better understanding of the
antioxidant capability of methyl gallate. In contrast to gallate esters, both paraben
derivatives were unable to reduce DPPH, even at higher molar ratios. Therefore, the results
of the DPPH scavenging assays demonstrated that gallate esters act as antioxidants through
free radical reduction, while parabens do not.
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To further support the findings of the DPPH assays and gain information about the
redox behavior of gallate esters in a more general sense, cyclic voltammetry (CV) was
completed for gallate esters, methyl- and butylparaben. Figure 13 shows the resulting,
combined voltammograms of all compounds studied, with gallate esters in shades of
red/pink and parabens in shades of blue.

Cyclic voltammograms of gallate esters vs. parabens
0.000008

Current (A)

0.000007
0.000006
0.000005
0.000004
0.000003
0.000002
0.000001
0

-0.000001 0
-0.000002

0.5

1

1.5

2

2.5

Potential (V vs. Ag/AgCl)

Figure 13. Combined cyclic voltammograms for gallate esters vs. parabens. Gallate
esters are in pink shades, while parabens are in blue. Electrodes included: Pt working,
Ag/AgCl (1M KCl) reference, and Pt metal counter. TBAP in acetonitrile (0.1M) was used
as the supporting electrolyte. All compounds were tested at 1 mM concentrations.
Parameters included an initial potential of +0.50 V for gallate esters, an initial potential
of +0.00 V for parabens, a vertex potential of +2.25 V for all compounds, and a scan rate
of 100 mV/s for all compounds

The cyclic voltammograms were then used to determine the oxidation potential(s) for each
compound studied, shown in Table 4, by finding the local maxima for each oxidation peak
identified.
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Table 4. Oxidation potentials of gallate esters using cyclic voltammetry.
Compound
Ferrocene
Methyl gallate
Ethyl gallate
Propyl gallate
Butyl gallate
Pentyl gallate
Hexyl gallate
Heptyl gallate
Octyl gallate
Decyl gallate
Dodecyl gallate
Methyl paraben
Butyl paraben

Peak 1 (V)
0.426
1.360
1.292
1.308
1.318
1.258
1.308
1.298
1.258
1.302
1.262
1.842
1.846

Peak 2 (V)
1.660
1.650
1.628
1.648
0.638
1.658
1.618
1.610
1.626
1.620
-

Peak Diff (V)
0.300
0.358
0.320
0.330
0.380
0.350
0.320
0.352
0.324
0.358
-

The CV data revealed that each gallate ester derivative undergoes two stable and
irreversible one-electron oxidations, showing two oxidation peaks and no reduction peaks.
On the other hand, parabens only exhibited one irreversible one-electron oxidation, with
only one oxidation peak and no reduction peaks. The first oxidation peaks for most gallate
ester derivatives ranged between 1.258 V and 1.318 V, an exception being methyl gallate
with a peak at 1.360 V, suggesting that methyl gallate may be slightly harder to oxidize
initially compared to the other derivatives. In contrast to gallates, the oxidation peaks for
methyl- and butylparaben were found to be 1.842 V and 1.846 V, respectively. The
potentials for parabens were higher overall than those of gallates, showing that more
voltage (or energy) is required to oxidize parabens relative to gallate esters, making
oxidation more difficult or unfavorable for parabens. The presence of two peaks relatively
close together for gallate esters also suggests that the second oxidation quickly follows the
first. This further supports the antioxidant properties of gallate esters, as the second
oxidation peak allows the radical to be eliminated through the formation of a quinone.
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Interestingly, the distance between peaks for methyl gallate was the lowest of all
derivatives tested with a value of 0.300 V, compared to a range of 0.320 – 0.380 V for all
other derivatives. While the first oxidation is likely harder for methyl gallate due to an
increased oxidation potential, the decreased difference between peaks could make the
second oxidation easier. This could explain the improved ARP values observed for methyl
gallate in the DPPH assays. Finally, the stabilization of a free radical through a second
oxidation is difficult for parabens as they only have one hydroxyl group, making radical
formation unfavorable and requiring a higher oxidation potential.
Overall, the oxidation potentials of gallates and parabens are consistent with the
results of the DPPH assay. Since low oxidation potentials correlate to higher ARP values,57
the lower oxidation potentials of gallate esters compared to parabens explains the ability
of gallates to reduce DPPH and the inability of parabens to do so. Additionally, the
oxidation potential of DPPH is likely lower than that of parabens, making it the preferable
radical of the two. The combination of both DPPH and CV demonstrates that gallate esters
are able to act as antioxidants due to their ability to undergo multiple oxidations in order
to scavenge and stabilize free radicals.
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Conclusions & Future Directions

This research was conducted to evaluate the safety of gallate esters, including their
estrogenic and redox activities. Before doing so, synthesis of four non-commercially
available gallate derivatives was completed via Fischer esterification and DCC coupling
methods. The full range of gallate esters were then evaluated for their antimicrobial
activities through microdilution assays to confirm their viability as preservative agents.
The results demonstrated that gallates can prevent bacterial growth comparable to
parabens, supporting the continuation of safety evaluation.
After confirmation of antimicrobial activity, the estrogenic activity was evaluated
through an estradiol colorimetric competition ELISA, with preliminary LDH cytotoxicity
and MTT proliferation assays. These assays revealed that gallate esters did not increase
cell proliferation, cause cell death, or upregulate estrogen activity of MCF-7 breast cancer
cells, while parabens both increased proliferation and upregulated estradiol production.
Additionally, this data, in combination with past work, further supports the role of gallates
as antagonists for the estrogen receptor. Finally, the antioxidant and redox properties of
gallate esters were evaluated using DPPH radical scavenging assays and cyclic
voltammetry. The results of both assays support that gallate esters can act as antioxidants
by reducing free radicals, while parabens are unable to.
In conclusion, gallate esters have shown significantly reduced estrogenic activity
and increased antioxidant properties, both of which should be considered when evaluating
their viability as paraben replacements. Provided this, gallate esters are not only a
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potentially safer alternative for traditional parabens but have an added benefit of acting as
antioxidants; therefore, they could one day be used in consumer products to eliminate the
risks associated with paraben-use. Future work includes TR-FRET binding assays for the
entire range of gallate esters to determine the magnitude of binding to the estrogen receptor,
as well as ELISA assays to determine the extent of antagonistic activity for the estrogen
receptor. It would also be valuable to further investigate whether parabens directly cause
oxidative DNA damage through free radical formation using biological assays, which
would confirm their involvement in breast cancer development via oxidative means.
Finally, other safety concerns of gallate esters should be evaluated, including
environmental toxicity and overall organismal toxicity. This information, in combination
with the results of this research, would provide even more reason to use gallate esters as a
replacement for traditional parabens in consumer products.
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Experimental Methods

Synthesis of gallate esters by Fischer esterification
Fischer esterification was performed within a 50 mL round bottom flask containing
approximately 2.00 g of gallic acid dissolved in 4 mL (excess) of the desired alcohol. Then,
20 drops of 18 M sulfuric acid were added to the solution. The resulting solution was then
heated at reflux overnight (~20 hours). Thin layer chromatography was used to monitor the
reaction progress. The crude reaction material was purified by flash column
chromatography on silica gel with approximately 400 mL of 15% ethyl acetate in hexanes
with 1% acetic acid, followed by approximately 350 mL of 50% ethyl acetate in hexanes.
The resulting fractions containing the final product were concentrated in vacuo to afford
an off-white, sometimes brown, solid as the final product.

Synthesis of gallate esters by DCC coupling
The DCC coupling reaction was performed in a 25 mL round bottom flask
containing approximately 340 mg of gallic acid and an equimolar volume of the desired
alcohol dissolved in 6 mL of THF. Then, approximately 870 mg (2.1 equiv.) of N,N’dicyclohexylcarbodiimide (DCC) was separately dissolved in 6 mL of THF and added to
the solution in the round bottom flask and cooled to 0º C. The reaction was stirred on ice
for approximately 8 hours and allowed to warm to room temperature for the remaining 12
hours. The crude reaction material was washed with ethyl acetate in triplicate and filtered.
The filtrate was then washed successively with 10% aqueous citric acid, saturated aqueous
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NaHCO3, and saturated NaCl, each in triplicate. The resulting organic layer was then
evaporated with MgSO4 and evaporated via rotary. Finally, the reaction was purified by
flash column chromatography on silica gel using approximately 400 mL of 30% ethyl
acetate in hexanes with 1% acetic acid, followed by approximately 350 mL of 50% ethyl
acetate in hexanes. The resulting fractions containing the final product were concentrated
in vacuo to afford a white solid as the final product.

Microdilution assay for Minimum Inhibitory Concentration (MIC) of gallate esters
Sterilized MHB was inoculated to 5 x 105 CFU mL-1 with S. aureus (OD600 =
0.00983; Carolina Biologicals 155554A), S. epidermidis (OD600 = 0.0570; Carolina
Biologicals 155556A), and S. marcescens (OD600 = 0.0790; Carolina Biologicals
155450A). Each inoculum was aliquoted (1 mL) into separate sterilized test tubes and the
resulting gallate ester derivative (from 16 mg/mL DMSO stocks) was added to give the
highest concentration to be tested (512 μg/mL). The resulting sample solutions were then
aliquoted (200 μL) into the top row of a 96-well plate while retaining the final well
(column) for untreated bacteria cells to act as the control. Rows 2 – 12 of the plate were
then aliquoted (100 μL) with the original, untreated inoculant. Row 1 wells were mixed 6
to 8 times, and then 100 μL was transferred to row 2. Row 2 wells were mixed 6 to 8 times,
followed by a 100 μL transfer from row 2 to row 3. This procedure was repeated to serially
dilute the rest of the rows of the microtiter plate, excluding the control column. The serially
diluted plate was then sealed with GLAD Press n’ Seal® and incubated under stationary
conditions at 37º C. After 16 hours of incubation, MIC values were recorded as the lowest
concentration of each test compound at which no visible growth of bacteria was observed.
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This process was repeated for a minimum of three days with each experiment consisting of
a pair of trials originating from two differing day cultures for a minimum of six biological
replicates.

MTT cellular proliferation assays
MCF-7 cells (human breast cancer call line with hormone receptor expression) were
used in this study. The cells were grown in complete RPMI media (Gibco Grand Island,
NY, USA) supplemented with 10% heat-inactivated fetal bovine serum (Gibco), 100 U/mL
penicillin, 100 μg/mL streptomycin, 1 nM sodium pyruvate, 10 mM Hepes, and 0.1 mM
non-essential amino acids in 5% CO2 atmosphere at 37º C. To determine the effect of the
gallate ester derivatives on cell proliferation, 2 x 105 cells were plated into flat-bottom 96well plates (Thermo Scientific Nunc, Waltham, MA) in 0.2 mL aliquots of complete
medium and treated with different concentrations of each compound (from 16 mg/mL
DMSO stocks). For comparison, ethylparaben, butylparaben and estradiol were used as
controls. Proliferation was determined after 24 and 72 hours of culture with the compounds
using a CellTiter 96 Non-radioactive Cell Proliferation Assay (MTT) according to the
manufacturer’s protocol (Promega Madison, WI). These protocols were then performed in
triplicate with three biological replicates on each plate. The percent proliferation was
determined using the following formula: ((Experimental optical density – untreated optical
density) / (Untreated optical density)) x 100.
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LDH cellular cytotoxicity assays
To determine the cytotoxicity of the gallate ester derivatives, 2 x 105 MCF-7 cells
were plated into flat-bottom 96-well plates in 0.2 mL aliquots of complete medium and
treated with different concentrations of each compound (from 16 mg/mL DMSO stocks).
For comparison, ethylparaben, butylparaben and estradiol were used as controls.
Cytotoxicity was determined after 24 and 72 hours of culture with the compounds using an
LDH cytotoxicity assay according to the manufacturer’s protocol (Thermo Scientific
Pierce). These protocols were then performed in triplicate with three biological replicates
on each plate. The percent cell death was determined by using the formula: ((Experimental
sample release – spontaneous release) / (Maximum release – spontaneous release)) x 100.

Estradiol colorimetric competition enzyme-linked immunosorbent assays (ELISA)
To determine if the gallate ester derivatives stimulated estradiol secretion from
MCF-7 cells, 2 x 105 cells were plated into flat-bottom 96-well plates in 0.2 mL aliquots
of complete medium and treated with different concentrations of each compound (from 16
mg/mL DMSO stocks). For comparison, ethylparaben and butylparaben were used as
controls. Estradiol secretion was determined after 24 hours of culture with the compounds
using a 17β – estradiol colorimetric competition ELISA kit according to the manufacturer’s
protocols (Enzo Life Sciences Farmingdale, NY). These protocols were performed in
triplicate with three biological replicates on each plate.
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DPPH radical scavenging assays
The methods for this assay were modified from those used in Brand-Williams et al60 and
are described as follows:
Antioxidant activities were determined using DPPH as a free radical. Each gallate
ester derivative was tested at different concentrations, expressed as the molar ratio of
compound/DPPH (ranged from 0.0125 to 2.00). For comparison, ethylparaben,
butylparaben, and ascorbic acid were used as controls. Each compound was accurately
diluted in HPLC-grade methanol prior to completion of the assays (from 10 mM in
methanol stocks), and a DPPH stock solution was accurately diluted to 0.5 mM in
methanol. All assays were performed in flat-bottom 96-well plates, in which all wells
received a 100 μL methanol aliquot. Then, 100 μL aliquots of 1.0 mM and 0.1 mM for each
compound were added to columns 1 and 7, respectively, excluding the top two rows.
Column 1 was then mixed 6 to 8 times, and then 100 μL was transferred from column 1 to
column 2. Column 2 was then mixed 6 to 8 times, followed by a 100 μL transfer from
column 2 to column 3. This process was repeated to serially dilute through column 6, after
which 100 μL was discarded. Then, the serial dilution procedure began again at column 7
through the remaining columns on the plate. At this point, a 100 μL aliquot of 0.5 mM
DPPH in methanol was added to all wells, excluding the top row of wells that acted as a
blank. The plate was covered with clear tape to prevent evaporation and the absorbance of
the solutions were measured at 0, 1, 5, 10, 20, 30, and 60 minutes using a Biotek ELx808
Microplate Reader with a 490 nm filter. These protocols were repeated in triplicate and
averaged for analysis.
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Before analysis, calibration curves were prepared for the DPPH radical (purple) and
the reduced DPPH (yellow) to account for the absorbance of both compounds at 490 nm.
The DPPH radical solutions were created by accurately diluting a 0.5 mM stock solution
in methanol to the appropriate concentrations, while the reduced DPPH solutions were
created by accurately diluting a 0.5 mM of DPPH with 1.0 mM ascorbic acid stock solution
in methanol. Figure 14 shows the resulting calibration curves, which were used to
determine the absorption coefficients of both compounds. These coefficients were then
used to calculate the percent of DPPH remaining with the following equation: [((Abs –
blank) – (yellow coefficient x starting [DPPH])) / (purple coefficient – yellow coefficient)]

Absorbance @ 490 nm
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Figure 14. Calibration curves for DPPH radical scavenging assays. A) Calibration curve
for purple-colored DPPH radical prior to antioxidant exposure. B) Calibration curve for
yellow-colored reduced DPPH radical after exposure to ascorbic acid, a known
antioxidant.

To determine the EC50 molar ratios for each compound, the molar ratio of the
compound/DPPH and 1 / percent of DPPH remaining after one hour were plotted to
produce linear plots. The trendline of each plot provided an equation that was used to
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determine the ratio at which 50% of DPPH would be remaining, or the EC50 molar ratios.
The ARP was then determined using the EC50 values in the following equation: 1 / EC50.

Cyclic voltammetry (CV)
The methods for cyclic voltammetry were modified from those used in Masek et al59 and
are described as follows:
Cyclic voltammetry was carried out with a Gamry Interface 1010T
potentiostat/galvanostat using platinum working, platinum metal counter, and Ag/AgCl
reference electrodes. All measurements were carried out at room temperature in
acetonitrile, with 0.1M tetrabutylammonium perchlorate (TBAP) as the supporting
electrolyte. The gallate ester derivatives were evaluated in acetonitrile at 1.0 mM
concentrations. For comparison, ethylparaben, butylparaben, and ferrocene were used as
controls at 1.0 mM concentrations in acetonitrile. The voltammetric parameters included
an initial potential of +0.50 V for gallate esters, an initial potential of +0.00 V for parabens,
a vertex potential of +2.25 V for all compounds, and a scan rate of 100 mV/s for all
compounds. The oxidation potential(s) for each compound was determined by subtracting
the voltammogram for TBAP alone and locating the local maxima for each oxidation peak.

Reeves 48
References

1

Cosmetic Ingredient Review Expert Panel. Int. J. Toxicol. 2008. 27(Suppl. 4): 1 - 82.

2

Darbre, PD; Aljarrah, A; Miller, WR; Coldham, NG; Sauer, MJ; Pope, GS. J. Appl.
Toxicol. 2004. 24(1): 5 – 13.
3

Liao, C; Liu, F; Kurunthachalam, K. Environ. Sci. Technol. 2013. 47(8): 3918 – 3925.

4

Liao, C; Kurunthachalam, K. Sci. Total Environ. 2014. 475: 8 – 15.

5

Nes, IF; Eklund, T. J. Appl. Bacteriol. 1983. 54(2): 237 – 242.

6

Ma, Y; Marquis, RE; Lett. Appl. Microbiol. 1996. 23(5): 329 – 333.

7

Goyral, S; Amar, SK; Kushwaha, HN; Singh, J; Srivastav, AK; Dubey, D; Chopra, D;
Ray, RS. Global Journal of Multidisciplinary Studies. 2014. 4(01): 77 – 86.
Mrozik, A; Piotrowska-Seget, Z; Labuzek, S. Pol. J. Environ. Stud. 2004. 13(5): 497 –
494.
8

9

Flasinski, M; Kowal, S; Broniatowski, M; Wydro, P. J. Phys. Chem. B. 2018. 122: 2332
– 2340.
10

Fukahori, M; Akatsu, S; Sato, H; Yotsuyanagi, T. Chem. Pharm. Bull. 1996. 44(8):
1567 – 1570.
Bredin, J; Davin-Regali, A; Pages, JM. J. Antimicrob. Chemother. 2005. 55: 1013 –
1015.
11

12

Grundling, A; mBio. 2013. 4(5): e00784 – 13.

13

Campos, FM; Couto, JA; Figueiredo, AR; Toth, IV; Rangel, AOSS; Hogg, TA. Int. J.
Food Microbiol. 2009. 135(2): 144 – 151.
Heipieper, HJ; Keweloh, H; Rehm, HJ. Appl. Environ. Microbiol. 1991. 57(4): 1213 –
1217.
14

15

Blair, RM; Fang, H; Branhan, WS; Hass, BS; Dial, SL; Moland, CL; Weida, T; Shi, L;
Perkins, R; Sheehan, DM. Toxicol. Sci. 2000. 54: 138 – 153.
Watson, CS; Bulayeva, NN; Wozniak, AN; Alyea, RA. Steroids. 2007. 72(2): 124 –
134.
16

17

Cui, J; Shen, Y; Li, R. Trends Mol. Med. 2013. 19(3): 197 – 209.

Reeves 49

18

Javed, A; Lteif, A. Seminars in Plastic Surgery. 2013. 27(1): 5 – 12.

19

Berga, S; Naftolin, F. Gynecol. Endocrinol. 2012. 28(sup 1): 9 -13.

20

Draper, CF; Duisters, K; Weger, B; Chakrabarti, A; Harms, AC; Brennan, L;
Hankemeier, T; Goulet, L; Konz, T; Martin, FP; Moco, S; van der Greef, J. Sci. Rep.
2018. 8(14568).
21

Paterni, I; Granchi, C; Katzenellenbogen, JA; Minutolo, F. Steroids. 2014. 0: 13 – 29.

22

Brzozowski, AM; Pike, ACW; Dauter, Z; Hubbard, RE; Bonn, T; Engstrom, O;
Ohman, L; Greene, GL; Gustafsson, JA; Carlquist, M. Nature. 1997. 389: 753 – 758.
23

Shiau, AK; Barstad, D; Loria, PM; Cheng, L; Kushner, PJ; Agard, DA; Greene, GL.
Cell. 1998. 95: 927 – 937.
24

Heldring, N; Pike, A; Anderson, S; Matthews, J; Cheng, G; Hartman, J; Tujague, M;
Strom, A; Truter, E; Warner, M. Physiol. Rev. 2007. 87: 905 – 931.
25

Byford, JR; Shaw, LE; Drew, MGB; Pope, GS; Sauer, MJ; Darbre, PD. J. Steroid
Biochem. Mol. Biol. 2002. 80: 49 – 60.
26

Bowes, DA; Halden, RU; Curr. Pathobiol. Rep. 2019. 7: 41 – 46.

Sato, H; Shibata, H; Shimizu, T; Toriumi, H; Ebine, T. Neuroscience. 2013. 248: 345 –
358.
27

28

Navarro-Yepes, J; Zavala-Flores, L; Anandhan, A; Wang, F; Skotak, M; Chandra, N.
Pharmacol. Ther. 2014. 142: 206 – 230.
29

Young, IS; Woodsie, JV. J. Clin. Pathol. 2001. 54: 176 – 186.

30

Valko, M; Morris, H; Cronin, MTD. Curr. Med. Chem. 2005. 12: 1161 - 1208.

31

Rajendran, P; Nandakumar, N; Rengarajan, T; Palaniswami, R; Gnanadhas, EN;
Lakshminarasaiah, U. Clin. Chim. Acta. 2014. 436: 332 – 347.
32

Pham-Huy, LA; Hua, H; Pham-Huy, C. Int. J. Biomed. Sci. 2008. 4(2): 89 – 96.

33

Pizzino, G; Irrera, N; Cucinotta, M; Giovanni, P; Mannino, F; Arcoraci, V; Squadrioto,
F; Altavilla, D; Bitto, A. Oxid. Med. Cell. Longevity. 2017. 2017: 8416763.
34

Wu, JQ; Kosten, TR; Zhang, XY. Prog. Neuro-Psychopharmacol. Biol. Psychiatry.
2013. 46: 200 – 206.

Reeves 50

35

Taniyama, Y; Griendling, KK. Hypertension. 2003. 42: 1075 – 1081.

36

Murray, AR; Kisin, E; Castranova, V; Kommineni, C; Gunther, MR; Shvedova, AA.
Chem. Res. Toxicol. 2007. 20: 1769 – 1777.
37

Shvedova, AA; Kommineni, C; Jeffries, BA; Castranova, V; Tyurina, YY; Tyurin, VA;
Serbinova, EA; Fabisiak, JP; Kagan, VE. J. Invest. Dermatol. 2000. 114(2): 354 – 364.
38

Popa, DS; Kiss, B; Vlase, L; Pop, A; Iepure, R; Paltinean, R; Loghin, F. Toxicol. Lett.
2011. 59(4): 539 – 549.
39

Nam, T. Toxicol. Res. 2011. 27(1): 1 – 6.

40

Yang, C; Lim, W; Bazer, FW; Song, G. Environ. Toxicol. 2018. 33: 436 – 445.

41

Valko, M; Izakovic, M; Mazur, M; Rhodes, CJ; Tesler, J. Mol. Cell. Biochem. 2004.
266(1-2): 37 – 56.
42

Lu, JM; Lin, PH; Yao, Q; Chen, C. J. Cell. Mol. Med. 2010. 14(4): 840 – 860.

43

Forman, HJ; Zhang, H; Rinna. Mol. Aspects Med. 2009. 30(1-2): 1 – 12.

44

Sroka, Z. Z. Zeitschrift fur Naturforschung C. 2005. 60(11-12): 833 – 843.

45

Hotta, H; Nagano, S; Ueda, M; Tsujino, Y; Koyama, J; Osakai, T. Biochim. Biophys.
Acta. 2002. 1572: 123 – 132.
46

Zeraik, ML. Petronio, MS; Coelho, D; Regasini, LO; Silva, DH; Fondeca, LMD;
Machado, SAS; Bolzani, VS; Ximenes, VF. PLoS ONE. 2014. 9(10): 1 – 9.
47

Benijts, T; Lambert, W; Leenheer, AD. Anal. Chem. 2004. 76(3): 704 – 711.

48

Lee, HB; Peart, TE; Svoboda, ML. J. Chromatogr. A. 2005. 1094(1-2): 122 – 129.

49

Canosa, P; Rodriguez, I; Rubi, E; Negreira, N; Cela, R. Anal. Chim. Acta. 2006.
575(1): 106 – 113.
50

Terasaki, M; Kamata, R; Shiraishi, F; Makino, M. Environ. Toxicol. Chem. 2009.
28(1): 204 – 208.
51

Bergquist, BL; Jefferson, KG; Kintz, HN; Barber, AE; Yeagley, AA. ACS Med. Chem.
Lett. 2018.
52

Sasaki, K; Terasaki, M. Environ. Sci. and Pollut. Res. 2018. 25: 21257 – 21266.

Reeves 51

53

Howe, PD; Dobson, S; Malcom, HM. Concise Int. Chem. Assess. Doc. 66. World
Health Organization: Geneva. 2005.
54

Renner, G. Toxicol. Environ. Chem. 1988. 18(1): 51 – 78.

55

Fisher, B. Journal of Pesticide Reform. 1991. 11(1): 1 – 5.

56

Brcanovic, JM; Pavlovic, AN; Mitic, SS; Stojanovic, GS; Manojlovic, DD; Kalicanin,
BM; Veljkovic, JN. Food Technol. Biotechnol. 2013. 51(4): 460 – 470.
57

Arteaga, JF; Ruiz-Montoya, M; Palma, A; Alonso-Garrido, G; Pintado, S; RodriguezMellado, JM. Molecules. 2012. 17: 5126 – 5138.
58

Gil, ES; Andrade, CH; Barbosa, NL; Braga, RC; Serrano, SHP. J. Braz. Chem. Soc.
2012. 23: 565 – 572.
59

Masek, A; Chrzescijanska, E; Zaborski, M; Piotrowska, M. C. R. Chim. 2014. 17: 1116
– 1127.
60

Brand-Williams, W; Cuvelier, ME; Berset, C. Lebensm.-Wiss. Technol. 1995. 28(1): 25
– 30.

